Suppr超能文献

HPV 自我采样作为宫颈筛查不参与者的替代策略 - 一项随机对照试验。

HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial.

机构信息

Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.

出版信息

Br J Cancer. 2011 Mar 15;104(6):915-20. doi: 10.1038/bjc.2011.48. Epub 2011 Feb 22.

Abstract

BACKGROUND

A randomised trial to ascertain whether women who do not attend for cervical screening are more likely to respond to the opportunity to collect a self-sample for human papillomavirus (HPV) testing, or to a further invitation to attend for cervical screening.

METHODS

The study was carried out in a Primary Care Trust (PCT) in London between June 2009 and December 2009. In total, 3000 women were randomly selected from persistent non-responders (i.e., who had not responded to at least two invitations to attend for screening). The women were randomised on a 1 : 1 basis to either receive an HPV self-sampling kit or a further invitation to attend for cervical cytology. The main outcome measures were (1) percentage of women attending for cervical cytology compared with those returning a self-sample HPV test or attending for cytology subsequent to receiving the kit and (2) percentage of those testing positive for HPV who attended further investigation.

RESULTS

The total response in the self-sampling group for screening was 10.2%. Of the 1500 women in the control group sent a further invitation for cervical screening, 4.5% attended for cytology screening. This difference is highly statistically significant (P<0.0001). Of the 8 women who tested positive for HPV, 7 attended for a cervical smear and had a concurrent colposcopy. Three of these (43%) had high-grade disease (defined as CIN 2+), with one found to have an invasive cancer (stage 1b) and one CIN 3.

CONCLUSIONS

The value of this intervention relies on the detection of high-grade CIN and early stage cancer with a good prognosis. The relatively high yield of abnormalities found is consistent with that expected among a hard to reach and relatively high-risk group of women. Our study suggests that self-sampling could increase participation among non-responders in England, but further work is needed to ascertain whether the low response rate seen here is likely to be representative of the rest of the country. Other studies are needed to investigate the response to self-sampling in different demographic and geographic settings.

摘要

背景

一项随机试验旨在确定未参加宫颈筛查的女性是否更有可能响应收集人乳头瘤病毒(HPV)检测自我样本的机会,或者更有可能响应进一步参加宫颈筛查的邀请。

方法

该研究于 2009 年 6 月至 2009 年 12 月在伦敦的一个初级保健信托基金(PCT)进行。总共从持续未应答者(即至少两次未响应参加筛查的邀请)中随机选择了 3000 名女性。这些女性按照 1:1 的比例随机分为接受 HPV 自我采样试剂盒或进一步参加宫颈细胞学检查的两组。主要结局指标是(1)与返回 HPV 自我样本检测或接受试剂盒后进行细胞学检查的女性相比,接受宫颈细胞学检查的女性比例;(2)HPV 检测阳性的女性中进一步接受检查的比例。

结果

自我采样组的总筛查参与率为 10.2%。在对照组中,有 1500 名女性收到了进一步的宫颈筛查邀请,其中 4.5%接受了细胞学筛查。这一差异具有高度统计学意义(P<0.0001)。在 8 名 HPV 检测阳性的女性中,有 7 名接受了宫颈涂片检查,并同时进行了阴道镜检查。其中 7 人(43%)患有高级别疾病(定义为 CIN2+),其中 1 人发现患有浸润性癌症(1b 期),1 人患有 CIN3。

结论

这种干预措施的价值在于检测到预后良好的高级别 CIN 和早期癌症。异常情况的相对高检出率与在难以接触且风险相对较高的女性群体中预期的情况一致。我们的研究表明,自我采样可以增加英格兰未应答者的参与率,但需要进一步的工作来确定这里看到的低应答率是否代表全国其他地区的情况。还需要其他研究来调查在不同人口统计学和地理环境下自我采样的反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/138f/3065284/9fab06ebd6d2/bjc201148f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验